% alzhub.org library filter
% Source: https://alzhub.org/research?author=Andreasen+N
% 30 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{honig2018-29365294,
  author  = {Honig, L. S. and Vellas, B. and Woodward, M. and Boada, M. and Bullock, R. and Borrie, M. and Hager, K. and Andreasen, N. and others},
  title   = {{Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2018},
  doi     = {10.1056/nejmoa1705971},
  pmid    = {29365294},
  url     = {https://doi.org/10.1056/nejmoa1705971}
}

@article{mattsson2009-19622817,
  author  = {Mattsson, N. and Zetterberg, H. and Hansson, O. and Andreasen, N. and Parnetti, L. and Jonsson, M. and Herukka, S. K. and van der Flier, W. M. and others},
  title   = {{CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment}},
  journal = {JAMA},
  year    = {2009},
  doi     = {10.1001/jama.2009.1064},
  pmid    = {19622817},
  url     = {https://doi.org/10.1001/jama.2009.1064}
}

@article{coric2012-22892585,
  author  = {Coric, V. and van Dyck, C. H. and Salloway, S. and Andreasen, N. and Brody, M. and Richter, R. W. and Soininen, H. and Thein, S. and others},
  title   = {{Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2012},
  doi     = {10.1001/archneurol.2012.2194},
  pmid    = {22892585},
  url     = {https://doi.org/10.1001/archneurol.2012.2194}
}

@article{coric2015-26414022,
  author  = {Coric, V. and Salloway, S. and van Dyck, C. H. and Dubois, B. and Andreasen, N. and Brody, M. and Curtis, C. and Soininen, H. and others},
  title   = {{Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2015.0607},
  pmid    = {26414022},
  url     = {https://doi.org/10.1001/jamaneurol.2015.0607}
}

@article{winblad2007-17380489,
  author  = {Winblad, B. and Cummings, J. and Andreasen, N. and Grossberg, G. and Onofrj, M. and Sadowsky, C. and Zechner, S. and Nagel, J. and others},
  title   = {{A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule}},
  journal = {International journal of geriatric psychiatry},
  year    = {2007},
  doi     = {10.1002/gps.1788},
  pmid    = {17380489},
  url     = {https://doi.org/10.1002/gps.1788}
}

@article{schneider2014-24605808,
  author  = {Schneider, L. S. and Mangialasche, F. and Andreasen, N. and Feldman, H. and Giacobini, E. and Jones, R. and Mantua, V. and Mecocci, P. and others},
  title   = {{Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014}},
  journal = {Journal of internal medicine},
  year    = {2014},
  doi     = {10.1111/joim.12191},
  pmid    = {24605808},
  url     = {https://doi.org/10.1111/joim.12191}
}

@article{andreasen2015-25789616,
  author  = {Andreasen, N. and Simeoni, M. and Ostlund, H. and Lisjo, P. I. and Fladby, T. and Loercher, A. E. and Byrne, G. J. and Murray, F. and others},
  title   = {{First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study}},
  journal = {PloS one},
  year    = {2015},
  doi     = {10.1371/journal.pone.0098153},
  pmid    = {25789616},
  url     = {https://doi.org/10.1371/journal.pone.0098153}
}

@article{mattsson2012-22302554,
  author  = {Mattsson, N. and Rosén, E. and Hansson, O. and Andreasen, N. and Parnetti, L. and Jonsson, M. and Herukka, S. K. and van der Flier, W. M. and others},
  title   = {{Age and diagnostic performance of Alzheimer disease CSF biomarkers}},
  journal = {Neurology},
  year    = {2012},
  doi     = {10.1212/wnl.0b013e3182477eed},
  pmid    = {22302554},
  url     = {https://doi.org/10.1212/wnl.0b013e3182477eed}
}

@article{buerger2002-12164722,
  author  = {Buerger, K. and Zinkowski, R. and Teipel, S. J. and Tapiola, T. and Arai, H. and Blennow, K. and Andreasen, N. and Hofmann-Kiefer, K. and others},
  title   = {{Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231}},
  journal = {Archives of neurology},
  year    = {2002},
  doi     = {10.1001/archneur.59.8.1267},
  pmid    = {12164722},
  url     = {https://doi.org/10.1001/archneur.59.8.1267}
}

@article{farlow2015-25918556,
  author  = {Farlow, M. R. and Andreasen, N. and Riviere, M. E. and Vostiar, I. and Vitaliti, A. and Sovago, J. and Caputo, A. and Winblad, B. and others},
  title   = {{Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2015},
  doi     = {10.1186/s13195-015-0108-3},
  pmid    = {25918556},
  url     = {https://doi.org/10.1186/s13195-015-0108-3}
}

@article{hampel2004-14706948,
  author  = {Hampel, H. and Buerger, K. and Zinkowski, R. and Teipel, S. J. and Goernitz, A. and Andreasen, N. and Sjoegren, M. and DeBernardis, J. and others},
  title   = {{Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study}},
  journal = {Archives of general psychiatry},
  year    = {2004},
  doi     = {10.1001/archpsyc.61.1.95},
  pmid    = {14706948},
  url     = {https://doi.org/10.1001/archpsyc.61.1.95}
}

@article{kvartsberg2015-25533203,
  author  = {Kvartsberg, H. and Duits, F. H. and Ingelsson, M. and Andreasen, N. and Öhrfelt, A. and Andersson, K. and Brinkmalm, G. and Lannfelt, L. and others},
  title   = {{Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2015},
  doi     = {10.1016/j.jalz.2014.10.009},
  pmid    = {25533203},
  url     = {https://doi.org/10.1016/j.jalz.2014.10.009}
}

@article{andreasen2001-11255440,
  author  = {Andreasen, N. and Minthon, L. and Davidsson, P. and Vanmechelen, E. and Vanderstichele, H. and Winblad, B. and Blennow, K.},
  title   = {{Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice}},
  journal = {Archives of neurology},
  year    = {2001},
  doi     = {10.1001/archneur.58.3.373},
  pmid    = {11255440},
  url     = {https://doi.org/10.1001/archneur.58.3.373}
}

@article{zettergren2019-30792413,
  author  = {Zettergren, A. and Höglund, K. and Kern, S. and Thorvaldsson, V. and Johan Skoog, M. and Hansson, O. and Andreasen, N. and Bogdanovic, N. and others},
  title   = {{Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein}},
  journal = {Scientific reports},
  year    = {2019},
  doi     = {10.1038/s41598-018-36650-3},
  pmid    = {30792413},
  url     = {https://doi.org/10.1038/s41598-018-36650-3}
}

@article{prince2004-15184629,
  author  = {Prince, J. A. and Zetterberg, H. and Andreasen, N. and Marcusson, J. and Blennow, K.},
  title   = {{APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42}},
  journal = {Neurology},
  year    = {2004},
  doi     = {10.1212/01.wnl.0000128088.08695.05},
  pmid    = {15184629},
  url     = {https://doi.org/10.1212/01.wnl.0000128088.08695.05}
}

@article{andreasen1999-10369305,
  author  = {Andreasen, N. and Hesse, C. and Davidsson, P. and Minthon, L. and Wallin, A. and Winblad, B. and Vanderstichele, H. and Vanmechelen, E. and others},
  title   = {{Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease}},
  journal = {Archives of neurology},
  year    = {1999},
  doi     = {10.1001/archneur.56.6.673},
  pmid    = {10369305},
  url     = {https://doi.org/10.1001/archneur.56.6.673}
}

@article{olsson2005-15563479,
  author  = {Olsson, A. and Vanderstichele, H. and Andreasen, N. and De Meyer, G. and Wallin, A. and Holmberg, B. and Rosengren, L. and Vanmechelen, E. and others},
  title   = {{Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology}},
  journal = {Clinical chemistry},
  year    = {2005},
  doi     = {10.1373/clinchem.2004.039347},
  pmid    = {15563479},
  url     = {https://doi.org/10.1373/clinchem.2004.039347}
}

@article{andreasen1999-10505638,
  author  = {Andreasen, N. and Minthon, L. and Vanmechelen, E. and Vanderstichele, H. and Davidsson, P. and Winblad, B. and Blennow, K.},
  title   = {{Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment}},
  journal = {Neuroscience letters},
  year    = {1999},
  doi     = {10.1016/s0304-3940(99)00617-5},
  pmid    = {10505638},
  url     = {https://doi.org/10.1016/s0304-3940(99)00617-5}
}

@article{herukka2017-28341066,
  author  = {Herukka, S. K. and Simonsen, A. H. and Andreasen, N. and Baldeiras, I. and Bjerke, M. and Blennow, K. and Engelborghs, S. and Frisoni, G. B. and others},
  title   = {{Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2017},
  doi     = {10.1016/j.jalz.2016.09.009},
  pmid    = {28341066},
  url     = {https://doi.org/10.1016/j.jalz.2016.09.009}
}

@article{solomon2012-22631442,
  author  = {Solomon, A. and Akenine, U. and Andreasen, N. and Mangialasche, F. and Wimo, A. and Jelic, V. and Kivipelto, M. and Winblad, B.},
  title   = {{Practical lessons from amyloid immunotherapy trials in Alzheimer disease}},
  journal = {Current Alzheimer research},
  year    = {2012},
  doi     = {10.2174/156720512804142958},
  pmid    = {22631442},
  url     = {https://doi.org/10.2174/156720512804142958}
}

@article{ohrfelt2009-19022350,
  author  = {Ohrfelt, A. and Grognet, P. and Andreasen, N. and Wallin, A. and Vanmechelen, E. and Blennow, K. and Zetterberg, H.},
  title   = {{Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?}},
  journal = {Neuroscience letters},
  year    = {2009},
  doi     = {10.1016/j.neulet.2008.11.015},
  pmid    = {19022350},
  url     = {https://doi.org/10.1016/j.neulet.2008.11.015}
}

@article{vanmechelen2000-10788705,
  author  = {Vanmechelen, E. and Vanderstichele, H. and Davidsson, P. and Van Kerschaver, E. and Van Der Perre, B. and Sjögren, M. and Andreasen, N. and Blennow, K.},
  title   = {{Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization}},
  journal = {Neuroscience letters},
  year    = {2000},
  doi     = {10.1016/s0304-3940(00)01036-3},
  pmid    = {10788705},
  url     = {https://doi.org/10.1016/s0304-3940(00)01036-3}
}

@article{eyjolfsdottir2016-27389402,
  author  = {Eyjolfsdottir, H. and Eriksdotter, M. and Linderoth, B. and Lind, G. and Juliusson, B. and Kusk, P. and Almkvist, O. and Andreasen, N. and others},
  title   = {{Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device}},
  journal = {Alzheimer's research \& therapy},
  year    = {2016},
  doi     = {10.1186/s13195-016-0195-9},
  pmid    = {27389402},
  url     = {https://doi.org/10.1186/s13195-016-0195-9}
}

@article{olsson2003-12957490,
  author  = {Olsson, A. and Höglund, K. and Sjögren, M. and Andreasen, N. and Minthon, L. and Lannfelt, L. and Buerger, K. and Möller, H. J. and others},
  title   = {{Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients}},
  journal = {Experimental neurology},
  year    = {2003},
  doi     = {10.1016/s0014-4886(03)00027-x},
  pmid    = {12957490},
  url     = {https://doi.org/10.1016/s0014-4886(03)00027-x}
}

@article{lee2008-18703769,
  author  = {Lee, J. M. and Blennow, K. and Andreasen, N. and Laterza, O. and Modur, V. and Olander, J. and Gao, F. and Ohlendorf, M. and others},
  title   = {{The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients}},
  journal = {Clinical chemistry},
  year    = {2008},
  doi     = {10.1373/clinchem.2008.104497},
  pmid    = {18703769},
  url     = {https://doi.org/10.1373/clinchem.2008.104497}
}

@article{jonsson2006-16676288,
  author  = {Jönsson, L. and Eriksdotter Jönhagen, M. and Kilander, L. and Soininen, H. and Hallikainen, M. and Waldemar, G. and Nygaard, H. and Andreasen, N. and others},
  title   = {{Determinants of costs of care for patients with Alzheimer's disease}},
  journal = {International journal of geriatric psychiatry},
  year    = {2006},
  doi     = {10.1002/gps.1489},
  pmid    = {16676288},
  url     = {https://doi.org/10.1002/gps.1489}
}

@article{tarkowski2003-12933918,
  author  = {Tarkowski, E. and Andreasen, N. and Tarkowski, A. and Blennow, K.},
  title   = {{Intrathecal inflammation precedes development of Alzheimer's disease}},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  year    = {2003},
  doi     = {10.1136/jnnp.74.9.1200},
  pmid    = {12933918},
  url     = {https://doi.org/10.1136/jnnp.74.9.1200}
}

@article{winblad2014-24476230,
  author  = {Winblad, B. and Graf, A. and Riviere, M. E. and Andreasen, N. and Ryan, J. M.},
  title   = {{Active immunotherapy options for Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2014},
  doi     = {10.1186/alzrt237},
  pmid    = {24476230},
  url     = {https://doi.org/10.1186/alzrt237}
}

@article{puchades2003-14559363,
  author  = {Puchades, M. and Hansson, S. F. and Nilsson, C. L. and Andreasen, N. and Blennow, K. and Davidsson, P.},
  title   = {{Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease}},
  journal = {Brain research. Molecular brain research},
  year    = {2003},
  doi     = {10.1016/j.molbrainres.2003.08.005},
  pmid    = {14559363},
  url     = {https://doi.org/10.1016/j.molbrainres.2003.08.005}
}

@article{hardy2014-24749173,
  author  = {Hardy, J. and Bogdanovic, N. and Winblad, B. and Portelius, E. and Andreasen, N. and Cedazo-Minguez, A. and Zetterberg, H.},
  title   = {{Pathways to Alzheimer's disease}},
  journal = {Journal of internal medicine},
  year    = {2014},
  doi     = {10.1111/joim.12192},
  pmid    = {24749173},
  url     = {https://doi.org/10.1111/joim.12192}
}